Effect of immunoglobulin G (IgG) interchain disulfide bond cleavage on efficacy of intravenous immunoglobulin for immune thrombocytopenic purpura (ITP)

被引:15
|
作者
Machino, Y. [1 ]
Ohta, H. [1 ]
Suzuki, E. [1 ]
Higurashi, S. [1 ]
Tezuka, T. [1 ]
Nagashima, H. [1 ]
Kohroki, J. [1 ]
Masuho, Y. [1 ]
机构
[1] Tokyo Univ Sci, Fac Pharmaceut Sci, Chiba 2788510, Japan
来源
CLINICAL AND EXPERIMENTAL IMMUNOLOGY | 2010年 / 162卷 / 03期
关键词
Fc receptors; idiopathic thrombocytopaenia purpuria; thrombocytopenia; intravenous immunoglobulin therapy; platelets; protein structure; folding; FC-GAMMA-RIII; RECEPTOR; GLOBULIN; CELLS; FRAGMENTS; ANTIBODY; BINDING; IVIG; MODULATION; COMPLEX;
D O I
10.1111/j.1365-2249.2010.04255.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
P>Intravenous immunoglobulin (IVIG) has been used widely to treat immune thrombocytopenic purpura (ITP), but the mechanisms of its action remain unclear. We investigated the affinity for Fc gamma receptors (Fc gamma Rs) and the thrombocytopenia-ameliorating effect of S-sulfonated gammaglobulin (SGG) and S-alkylated gammaglobulin (AGG), in comparison with unmodified gammaglobulin (GG), in a mouse ITP model. Cleavage of immunoglobulin (Ig)G interchain disulfide bonds by either S-sulfonation or S-alkylation did not decrease the affinity for Fc gamma RIIA (CD32A) and Fc gamma RIIB (CD32B), but did decrease the affinity for Fc gamma RIA (CD64A) and Fc gamma RIIIA (CD16A), presumably because of changes in H-chain configuration. The interchain disulfide bond cleavage decreased the affinity much more for mouse Fc gamma RIV than for mouse Fc gamma RIIB. The ability of AGG to ameliorate ITP was greatly diminished, while SGG, whose disulfide bonds are reconstituted in vivo, was as effective as GG. These results suggest that the interchain disulfide bonds are important for therapeutic effect. It is also suggested that the interaction of IVIG with the inhibitory receptor Fc gamma RIIB is insufficient for effective amelioration of ITP and that, at least in this model, direct binding of IVIG to Fc gamma RIIIA is also required.
引用
收藏
页码:415 / 424
页数:10
相关论文
共 50 条
  • [1] THE EFFECT OF INTRAVENOUS IMMUNOGLOBULIN ON PLATELET KINETICS IN CHRONIC IMMUNE THROMBOCYTOPENIC PURPURA (ITP)
    BADENHORST, PN
    KOTZE, HF
    HEYNS, AD
    LOTTER, MG
    WESSELS, P
    ROODT, JP
    THROMBOSIS AND HAEMOSTASIS, 1987, 58 (01) : 482 - 482
  • [2] IMMUNE THROMBOCYTOPENIC PURPURA AND INTRAVENOUS IMMUNOGLOBULIN
    IMBACH, P
    CANCER, 1991, 68 (06) : 1422 - 1425
  • [3] INTRAVENOUS IMMUNOGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP) IN CHILDHOOD
    IMBACH, P
    BARANDUN, S
    HIRT, A
    WAGNER, HP
    AMERICAN JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1984, 6 (02): : 171 - 174
  • [4] Therapy of patients with chronic immune thrombocytopenic purpura (ITP): Efficacy, tolerability, and safety of a new nanoflltered intravenous immunoglobulin
    Wolf, HH
    Davies, S
    Smith, G
    Sklenar, I
    Adams, C
    Andresen, I
    7TH ANNUAL MEETING OF THE EUROPEAN HAEMATOLOGY ASSOCIATION, 2002, : 389 - 395
  • [5] Mechanisms of intravenous immunoglobulin action in immune thrombocytopenic purpura
    Jin, F
    Balthasar, JP
    HUMAN IMMUNOLOGY, 2005, 66 (04) : 403 - 410
  • [6] HIGH-DOSE INTRAVENOUS-(IV) IMMUNOGLOBULIN-G (IGG) THERAPY IN CHILDHOOD IMMUNE THROMBOCYTOPENIC PURPURA (ITP) - EVALUATION OF A MODIFIED PROTOCOL
    BLANCHETTE, V
    CHISHOLM, J
    LUKE, B
    HSU, E
    ROCK, G
    TRANSFUSION, 1983, 23 (05) : 432 - 432
  • [7] Treatment of immune thrombocytopenic purpura in pediatrics. Therapeutic efficacy of a regional intravenous immunoglobulin G.
    Buteler, C
    Colombo, H
    Gabosi, G
    Manfredi, MJ
    Montero, S
    Pasquali, MA
    Rougier, C
    Sisti, AM
    MEDICINA-BUENOS AIRES, 2001, 61 (05) : 522 - 528
  • [8] POSSIBLE MECHANISMS OF INTRAVENOUS IMMUNOGLOBULIN TREATMENT IN CHILDHOOD IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP)
    IMBACH, P
    JUNGI, TW
    BLUT, 1983, 46 (03): : 117 - 124
  • [9] Efficacy of Anti-D Immunoglobulin (Anti-D) and Intravenous Immunoglobulin(IVIg) in the Treatment of Acute Immune Thrombocytopenic Purpura (ITP) in Children. † 665
    Reneé M. Madden
    Salvatore J. Bertolone
    Ronald M. Kline
    Chandrakant C. Patel
    Cynthia E. Gonzales
    Donna L. Fennewald
    Michael D. Tarantino
    Pediatric Research, 1997, 41 (Suppl 4) : 113 - 113
  • [10] Aseptic meningitis a sign of efficacy or an adverse effect of intravenous immunoglobulin therapy in severe immune thrombocytopenic purpura?
    Kuhne, T
    Spitz, C
    Imbach, P
    BLOOD, 1996, 88 (10) : 2967 - 2967